UCB's Global Corporate Website
Welcome to UCB in the United States

The Impact of Immune-mediated Inflammatory Diseases (IMIDs): Considerations for Patients with Systemic Manifestations

Discusses the extra articular, extra intestinal, and extra cutaneous manifestations of disease and the skin/gut/joint inter-relationships to highlight the effects of systemic inflammation. It also reviews the humanistic and economic burdens of the systemic manifestations and comorbidities to highlight the impact they can have on patients and the healthcare system.

Want to Attend This Program?

*THERE ARE SOME ELIGIBILITY REQUIREMENTS TO ATTEND THESE PROGRAMS